| Avastin for PDR (Proliferative Diabetic Retinopathy) (NCT01270542) | University of Southern California | 2009-06-01 |
| Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study (NCT00855608) | Rafic Hariri University Hospital | 2009-03-01 |
| Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (NCT00931125) | Attila Vajas | 2009-03-01 |
| Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil (NCT01131650) | Hospital do Olho Rio Preto | 2009-03-01 |
| Diabetic Retinopathy Sulodexide Study (NCT01295775) | Ajou University School of Medicine | 2009-02-01 |
| The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong (NCT01628289) | The University of Hong Kong | 2009-02-01 |
| Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy (NCT01102946) | University of Sao Paulo | 2009-02-01 |
| Ranibizumab for Diabetic Traction Retinal Detachment (NCT01201161) | University of Sao Paulo | 2008-12-01 |
| Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography (NCT00797524) | Association for Innovation and Biomedical Research on Light and Image | 2008-11-01 |
| Retinal Thickness Analysis Using Optical Coherence Tomography (NCT00797134) | Association for Innovation and Biomedical Research on Light and Image | 2008-11-01 |
| Effect of Panretinal Photocoagulation on Optic Nerve Head Topography (NCT00767884) | University of Nebraska | 2008-10-29 |
| A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects (NCT00908778) | Vitreoretinal Technologies, Inc. | 2008-10-01 |
| A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy (NCT00904592) | Chengdu University of Traditional Chinese Medicine | 2008-09-01 |
| Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy (NCT00511875) | Thomas Gardner | 2008-07-01 |
| Sirolimus to Treat Diabetic Macular Edema (NCT00711490) | National Eye Institute (NEI) | 2008-07-01 |
| Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab (NCT00864838) | University of Sao Paulo | 2008-06-01 |
| Bevacizumab Versus Ranibizumab for Diabetic Retinopathy (NCT00545870) | Ursula Schmidt-Erfurth, M.D. | 2008-06-01 |
| Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (NCT00695682) | Retina Research Foundation | 2008-06-01 |
| Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema (NCT00701181) | Quark Pharmaceuticals | 2008-06-01 |
| Diabetic Retinopathy and Sickle Trait (NCT00720317) | Medical University of South Carolina | 2008-05-01 |
| The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy (NCT00849537) | Shahid Beheshti University of Medical Sciences | 2008-04-01 |
| Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema (NCT00900887) | Hospital Juarez de Mexico | 2008-04-01 |
| Genetics and Markers of Degenerative and Inflammatory Eye Diseases (NCT00647439) | National Eye Institute (NEI) | 2008-03-27 |
| Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) (NCT00690768) | University of Sao Paulo | 2008-03-01 |
| A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects (NCT00664183) | Vitreoretinal Technologies, Inc. | 2008-03-01 |
| Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population (NCT00799695) | Henry Ford Health System | 2008-01-01 |
| Pattern Laser Versus Conventional Laser in Diabetic Retinopathy (NCT03672656) | University Hospital Ostrava | 2008-01-01 |
| Preoperative Bevacizumab for Vitreous Hemorrhage (NCT00596297) | University of Sao Paulo | 2007-11-01 |
| Pharmacological Intervention in Diabetic Retinopathy (NCT00619034) | University of Aarhus | 2007-09-01 |
| Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 (NCT00763802) | Association for Innovation and Biomedical Research on Light and Image | 2007-09-01 |
| Treatment of Refractory Diabetic Macular Edema With Infliximab (NCT00505947) | University of Athens | 2007-07-01 |
| Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program (NCT00498147) | Group Health Centre | 2007-07-01 |
| Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM) (NCT00718614) | Medical University of Vienna | 2007-06-01 |
| A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) (NCT00457470) | Pfizer | 2007-06-01 |
| Unilateral Bevacizumab for Bilateral Diabetic Macular Edema (NCT00496405) | Asociación para Evitar la Ceguera en México | 2007-04-01 |
| Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema (NCT00444600) | Jaeb Center for Health Research | 2007-03-01 |
| Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries (NCT01075347) | National Taiwan University Hospital | 2007-03-01 |
| Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment (NCT00548197) | Iran University of Medical Sciences | 2007-02-01 |
| The Course of Response to Focal Photocoagulation for DME (NCT00442156) | Jaeb Center for Health Research | 2007-01-01 |
| A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging (NCT00556114) | University of California, Irvine | 2007-01-01 |
| Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients (NCT00524875) | Shahid Beheshti University of Medical Sciences | 2007-01-01 |
| Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy (NCT00712842) | Gerhard Garhofer | 2007-01-01 |
| Clinical Applications of Advanced Ophthalmic Imaging (NCT03135327) | University of Miami | 2007-01-01 |
| Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy (NCT00423059) | Yonsei University | 2006-12-01 |
| A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers (NCT00414999) | TargeGen | 2006-11-01 |
| Clinical and Pathophysiological Description of Ocular Ischemic Syndrome (NCT00403195) | Glostrup University Hospital, Copenhagen | 2006-11-01 |
| Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema (NCT00407849) | Federal University of São Paulo | 2006-10-01 |
| Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy (NCT00401115) | Santen Inc. | 2006-09-01 |
| The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes (NCT00337298) | University of Aarhus | 2006-07-01 |
| Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography (NCT01946997) | Johns Hopkins University | 2006-07-01 |
| Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy (NCT00411333) | National Eye Institute (NEI) | 2006-07-01 |
| Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema (NCT00387582) | Rocky Mountain Retina Consultants | 2006-07-01 |
| Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation (NCT00677664) | Federal University of São Paulo | 2006-07-01 |
| Diabetic Macular Edema Severity at Diagnosis (NCT00886392) | Hospital Juarez de Mexico | 2006-06-01 |
| Combined Triple Therapy in Diabetic Retinopathy (DRP) (NCT00806169) | Johann Wolfgang Goethe University Hospital | 2006-04-01 |
| Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) (NCT00370721) | Shahid Beheshti University of Medical Sciences | 2006-03-01 |
| Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy (NCT00347698) | Asociación para Evitar la Ceguera en México | 2006-03-01 |
| Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy (NCT00407108) | Asociación para Evitar la Ceguera en México | 2006-03-01 |
| Treatment for Completers of the Study B7A-MC-MBCM (NCT00266695) | Chromaderm, Inc. | 2006-01-01 |
| Visual Function, Center Point Thickness and Macular Volume After Photocoagulation (NCT00906659) | Hospital Juarez de Mexico | 2006-01-01 |
| A Pilot Study for the Treatment of Iris Neovascularization With Macugen (NCT00295828) | Hermann Eye Center | 2006-01-01 |
| Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy (NCT00355680) | Aurolab | 2005-12-01 |
| Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy (NCT00248131) | Novartis Pharmaceuticals | 2005-11-01 |
| Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy (NCT00248157) | Novartis Pharmaceuticals | 2005-11-01 |
| PST/Laser v. Laser Alone for CSME (NCT00229918) | Edward Hines Jr. VA Hospital | 2005-09-01 |
| Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema (NCT00231023) | National Eye Institute (NEI) | 2005-09-01 |
| Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment (NCT00198471) | Bausch & Lomb Incorporated | 2005-07-01 |
| Evaluation of Vitrectomy for Diabetic Macular Edema (NCT00709319) | Jaeb Center for Health Research | 2005-07-01 |
| Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training (NCT00500097) | Ministry of Health, Thailand | 2005-05-01 |
| Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation (NCT00105404) | National Eye Institute (NEI) | 2005-03-09 |
| Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy (NCT00443521) | University of Sao Paulo | 2005-03-01 |
| Tracking Optical Coherence Tomography (NCT00343603) | University of Pittsburgh | 2004-10-01 |
| Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy (NCT00155454) | National Taiwan University Hospital | 2004-09-01 |
| 20- Versus 23- Gauge System for Pars Plana Vitrectomy (NCT00411970) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2004-09-01 |
| Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes (NCT00119535) | US Department of Veterans Affairs | 2004-08-01 |
| Reduction in the Occurrence of Center-Involved Diabetic Macular Edema (NCT00090519) | Chromaderm, Inc. | 2004-02-01 |
| Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) (NCT00542178) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-10-01 |
| Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema (NCT00069056) | National Eye Institute (NEI) | 2003-09-10 |
| Retinal Blood Flow and Microthrombi in Type 1 Diabetes (NCT00406991) | Schepens Eye Research Institute | 2003-06-01 |
| Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study (NCT00041444) | University of Wisconsin, Madison | 2002-06-01 |
| Severe Proliferative Diabetic Retinopathy (NCT01115257) | University of Catania | 2001-10-01 |
| Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study (NCT00604383) | Chromaderm, Inc. | 2001-03-01 |
| Blood Factors and Diabetic Retinopathy (NCT00005761) | National Eye Institute (NEI) | 2000-05-23 |
| Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy (NCT00130845) | Novartis | 2000-02-01 |
| Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy (NCT00131144) | Novartis | 1999-11-01 |
| Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage (NCT00198497) | Bausch & Lomb Incorporated | 1999-06-01 |
| Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage (NCT00198510) | Bausch & Lomb Incorporated | 1998-11-01 |
| Screening for Studies on Retinovascular Diseases (NCT00001733) | National Eye Institute (NEI) | 1998-03-06 |
| Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS) (NCT00001612) | National Eye Institute (NEI) | 1997-05-01 |
| Long Term Follow-Up of Diabetic Retinopathy (NCT00001395) | National Eye Institute (NEI) | 1994-03-01 |
| Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) (NCT00594152) | Joslin Diabetes Center | 1993-01-01 |
| Diabetic Retinopathy and Visual Function Study (NCT00001346) | National Eye Institute (NEI) | 1992-11-01 |
| Tissue Studies of Human Eye Diseases (NCT00001310) | National Eye Institute (NEI) | 1992-03-05 |
| Krypton-Argon Regression of Neovascularization Study (KARNS) (NCT00000153) | National Eye Institute (NEI) | 1984-12-01 |
| Early Treatment Diabetic Retinopathy Study (ETDRS) (NCT00000151) | National Eye Institute (NEI) | 1979-12-01 |
| Diabetic Retinopathy Vitrectomy Study (DRVS) (NCT00000154) | National Eye Institute (NEI) | 1976-10-01 |
| Diabetic Retinopathy Study (DRS) (NCT00000160) | National Eye Institute (NEI) | 1972-01-01 |
| Intravitreal Bevacizumab for Diabetic Macular Edema (NCT00703235) | Isfahan Ophthalmology Research Center | |
| Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) (NCT00211406) | Manhattan Eye, Ear & Throat Hospital | |
| Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab (NCT00804921) | University of Sao Paulo | |